UCB SA (UCBJF)
OTCMKTS · Delayed Price · Currency is USD
276.21
-16.48 (-5.63%)
At close: Mar 20, 2026
UCB SA Employees
UCB SA had 9,765 employees as of December 31, 2025. The number of employees increased by 713 or 7.88% compared to the previous year.
Employees
9,765
Change (1Y)
713
Growth (1Y)
7.88%
Revenue / Employee
$930,761
Profits / Employee
$187,331
Market Cap
54.28B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 9,765 | 713 | 7.88% | 9,765 | 0 |
| Dec 31, 2024 | 9,052 | -31 | -0.34% | 9,052 | 0 |
| Dec 31, 2023 | 9,083 | 380 | 4.37% | 8,450 | 633 |
| Dec 31, 2022 | 8,703 | 142 | 1.66% | 8,108 | 595 |
| Dec 31, 2021 | 8,561 | 190 | 2.27% | 8,006 | 555 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vaxart | 105 |
| Silence Therapeutics | 88 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
| ZIVO Bioscience | 7 |
| Anebulo Pharmaceuticals | 3 |
| Vicapsys Life Sciences | 2 |
UCB SA News
- 9 days ago - Ex-Div Reminder for United Community Banks (UCB) - Nasdaq
- 9 days ago - UCB's Bimzelx Outperforms AbbVie's Skyrizi in Psoriatic Arthritis Trial - GuruFocus
- 17 days ago - Belgium's UCB in autoimmune drug deal with Antengene - Reuters
- 18 days ago - UCB SA (UCBJF) (FY 2025) Earnings Call Highlights: Record Growth and Strategic Investments ... - GuruFocus
- 18 days ago - Full Year 2025 Ucb SA Earnings Call Transcript - GuruFocus
- 18 days ago - Best Income Stocks to Buy for March 2nd - Nasdaq
- 4 months ago - U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d) - PRNewsWire